mRNA-LNPs expressing EGF and HGF (Boston University School of Medicine/Acuitas Therapeutics)

N/A

Report date: 2025/05/14 11:14:23

Base Information

Drug NamemRNA-LNPs expressing EGF and HGF (Boston University School of Medicine/Acuitas Therapeutics)

Drug Alias NameN/A

ClassificationSmall molecules > LipidCell and gene therapy > Gene therapy > mRNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide

Mechanisms of ActionEpidermal growth factor receptor erbB1 agonistsHepatocyte growth factor receptor agonists

TargetsEpidermal growth factor receptor erbB1Hepatocyte growth factor receptor

Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBoston University School of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesAcuitas Therapeutics Inc Boston University School of Medicine

Inactive CompaniesN/A

Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A